CRISIL Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Excellent return on equity (ROE 24.5%)
- Efficient capital deployment (ROCE 32.6%)
- Low debt relative to equity (D/E 0.1x)
Concerns
- High premium to book value (P/B 9.3x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| HDFCBANK HDFC Bank Limited | ₹685 | ₹10.7L Cr | 13.3 | 1.75 | 13.6 | 7.02 | — |
| ICICIBANK ICICI Bank Limited | ₹1,378 | ₹10.0L Cr | 17 | 2.55 | 15.9 | 7.18 | — |
| SBIN State Bank of India | ₹957 | ₹8.8L Cr | 10.5 | 1.42 | 15.4 | 6.13 | — |
| BAJFINANCE Bajaj Finance Limited | ₹917 | ₹5.8L Cr | 26.4 | 4.63 | 18.2 | 10.9 | — |
| LICI Life Insurance Corporation Of India | ₹391 | ₹4.8L Cr | 8.03 | 2.8 | 37.8 | 35.1 | 0 |
| KOTAKBANK Kotak Mahindra Bank Limited | ₹440 | ₹4.3L Cr | 20.2 | 2.24 | 11.4 | 6.98 | — |
| AXISBANK Axis Bank Limited | ₹1,220 | ₹3.8L Cr | 12.7 | 1.65 | 13.1 | 6.24 | — |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
CRISIL · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 66.65% | 66.65% | 66.64% | 66.64% | 66.64% | 66.64% |
| FII | 7.19% | 7.20% | 7.17% | 7.22% | 7.55% | 7.69% |
| DII | 12.92% | 12.94% | 12.49% | 12.70% | 12.69% | 12.38% |
| Public | 13.23% | 13.21% | 13.69% | 13.43% | 13.13% | 13.28% |
Corporate Events
Interim Dividend - Rs 17 Per Share
To consider and approve the financial results for the period ended September 30, 2026 and dividend
Interim Dividend - Rs 10 Per Share
To consider and approve the financial results for the period ended Jun 30, 2026 and dividend
Interim Dividend - Rs 9 Per Share
Dividend - Rs 28 Per Share
Record: 2 Apr 2026
Interim Dividend - Rs 16 Per Share
Interim Dividend - Rs 9 Per Share
Interim Dividend - Rs 8 Per Share
Dividend - Rs 26 Per Share
Record: 13 Apr 2025
Latest News
All newsAegis Vopak Terminals receives credit rating update
*Aegis Vopak Terminals receives credit rating update.* The facility has been rated by CRISIL, with the long-term rating assigned at **BBB+** and short-term at **P2+**, indicating adequate safety of debt obligations. The outlook on the ratings is stable. The rating reflects the company's operational performance and debt servicing ability. 📊 *STOCKS:* $AEGISLOG | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #CreditRating
Can Fin Homes receives new credit rating
*Can Fin Homes receives new credit rating.* The company's latest credit assessment reflects stable creditworthiness with **CRISIL** and **ICRA** affirming ratings. No changes in outlook were indicated. This routine update supports ongoing debt market operations. 📊 *STOCKS:* CANFINHOME | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #CreditRating
Crisil assigns AA/Stable rating to CleanMax
*Crisil assigns AA/Stable rating to CleanMax* reflecting strong market leadership and prudent financial management. The rating underscores confidence in the company’s credit profile and growth strategy. **CRISIL AA** rating indicates low credit risk with stable outlook. This recognition may enhance investor interest and lower borrowing costs. 📊 *STOCKS:* CLEANMAX | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #CreditRating
Crisil publishes mandatory newspaper notice for shareholders
*Crisil publishes mandatory newspaper notice for shareholders.* This is a routine corporate disclosure as per regulatory norms. No financial or operational impact is expected. Such filings are standard practice for listed entities. 📊 *STOCKS:* $CRISIL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #corporate_filing
Crisil declares ₹17 per share dividend, record date set
*Crisil declares ₹17 per share dividend with record date announced.* The company reported Q2 results and saw its stock rise **7% in 2 weeks**. Dividend signals strong cash flow and shareholder returns. 📊 *STOCKS:* $CRISIL | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #Dividend
Steel Strips Wheels receives ESG rating of 64
*Steel Strips Wheels receives ESG rating of 64* Steel Strips Wheels Limited has been assigned an ESG rating of **64** by CRISIL ESG Ratings, placing it in the **Strong** category. The rating reflects the company’s environmental, social, and governance performance based on publicly available data. This voluntary assessment enhances transparency but has limited immediate financial impact. 📊 *STOCKS:* SSWL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #ESG
Supriya Lifescience receives ESG rating from CRISIL
*Supriya Lifescience receives ESG rating from CRISIL*. CRISIL has assigned an ESG rating to Supriya Lifescience Limited, reflecting its environmental, social, and governance performance. The rating may influence investor sentiment over the long term. No financial figures or immediate business changes were disclosed. 📊 *STOCKS:* $SUPRIYA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ESG
Goldiam International receives ESG rating from CRISIL
*Goldiam International receives ESG rating from CRISIL.* The company has been assigned an **ESG rating** by Crisil ESG Ratings & Analytics Limited, marking a step toward greater sustainability disclosure. While the exact score isn't disclosed, ESG ratings can influence institutional investor interest. This is a routine corporate update with no immediate financial impact. 📊 *STOCKS:* $GOLDIAMLTD | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #ESG
RITES receives ESG rating from CRISIL
*RITES receives ESG rating from CRISIL* — RITES Limited has been assigned an ESG rating by CRISIL ESG Ratings & Analytics Limited. The rating reflects the company’s environmental, social, and governance performance. While positive for long-term investor sentiment, no immediate financial impact is expected. 📊 *STOCKS:* $RITES | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #ESG
Shilpa Medicare assigned ESG rating by CRISIL
*Shilpa Medicare assigned ESG rating by CRISIL* CRISIL ESG Ratings has assigned an ESG score to Shilpa Medicare, marking a step in sustainability disclosure. While the rating reflects improved transparency, it does not imply immediate financial impact. The move may support long-term investor sentiment. 📊 *STOCKS:* $SHILPAMED | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ESG
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.1K Cr 2.2% | ₹1.1K Cr 18.8% | ₹911 Cr 8.1% | ₹843 Cr 3.7% | ₹813 Cr 11.0% | ₹913 Cr 12.4% | ₹812 Cr 1.9% | ₹797 Cr |
| Op. Profit | ₹319 Cr 6.2% | ₹340 Cr 29.3% | ₹263 Cr 10.0% | ₹239 Cr 3.0% | ₹232 Cr 19.2% | ₹287 Cr 28.1% | ₹224 Cr 8.2% | ₹207 Cr |
| OPM | 30.0% 3.2% | 31.0% 6.9% | 29.0% 3.6% | 28.0% 3.4% | 29.0% 6.5% | 31.0% 10.7% | 28.0% 7.7% | 26.0% |
| Net Profit | ₹233 Cr 3.7% | ₹242 Cr 25.4% | ₹193 Cr 12.2% | ₹172 Cr 7.5% | ₹160 Cr 28.9% | ₹225 Cr 30.8% | ₹172 Cr 14.7% | ₹150 Cr |
| EPS (₹) | 31.9 3.4% | 33.02 25.0% | 26.41 12.6% | 23.46 7.3% | 21.86 28.8% | 30.72 30.9% | 23.46 14.3% | 20.53 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹3.6K Cr 11.9% | ₹3.3K Cr 3.8% | ₹3.1K Cr 13.4% | ₹2.8K Cr 20.3% | ₹2.3K Cr 16.1% | ₹2.0K Cr 14.4% | ₹1.7K Cr 0.9% | ₹1.7K Cr 5.4% | ₹1.7K Cr |
| Expenses | ₹2.6K Cr 9.2% | ₹2.3K Cr 4.0% | ₹2.3K Cr 10.7% | ₹2.0K Cr 20.7% | ₹1.7K Cr 14.9% | ₹1.5K Cr 15.3% | ₹1.3K Cr 0.1% | ₹1.3K Cr 6.2% | ₹1.2K Cr |
| Op. Profit | ₹1.1K Cr 19.1% | ₹911 Cr 3.3% | ₹882 Cr 20.8% | ₹730 Cr 19.5% | ₹611 Cr 19.6% | ₹511 Cr 12.1% | ₹456 Cr 3.2% | ₹471 Cr 3.5% | ₹455 Cr |
| OPM | 30.0% 7.1% | 28.0% 0.0% | 28.0% 7.7% | 26.0% 3.7% | 27.0% 3.8% | 26.0% 0.0% | 26.0% 3.7% | 27.0% 0.0% | 27.0% |
| Other Income | ₹107 Cr 18.9% | ₹90 Cr 4.3% | ₹94 Cr 23.0% | ₹122 Cr 0.8% | ₹123 Cr 48.2% | ₹83 Cr 13.7% | ₹73 Cr 0.0% | ₹73 Cr 192.0% | ₹25 Cr |
| Interest | ₹22 Cr 450.0% | ₹4 Cr 0.0% | ₹4 Cr 33.3% | ₹6 Cr 33.3% | ₹9 Cr 35.7% | ₹14 Cr | ₹0 Cr 100.0% | ₹2 Cr | ₹0 Cr |
| Depreciation | ₹129 Cr 84.3% | ₹70 Cr 32.7% | ₹104 Cr 1.0% | ₹103 Cr 2.8% | ₹106 Cr 12.4% | ₹121 Cr 227.0% | ₹37 Cr 14.0% | ₹43 Cr 8.5% | ₹47 Cr |
| PBT | ₹1.0K Cr 12.4% | ₹926 Cr 6.7% | ₹868 Cr 17.0% | ₹742 Cr 20.1% | ₹618 Cr 34.9% | ₹458 Cr 6.9% | ₹492 Cr 1.6% | ₹500 Cr 15.2% | ₹434 Cr |
| Tax % | 26.0% 0.0% | 26.0% 8.3% | 24.0% 0.0% | 24.0% 4.0% | 25.0% 8.7% | 23.0% 23.3% | 30.0% 11.1% | 27.0% 10.0% | 30.0% |
| Net Profit | ₹766 Cr 12.0% | ₹684 Cr 4.0% | ₹658 Cr 16.7% | ₹564 Cr 21.0% | ₹466 Cr 31.3% | ₹355 Cr 3.2% | ₹344 Cr 5.2% | ₹363 Cr 19.4% | ₹304 Cr |
| EPS (₹) | 104.75 12.0% | 93.54 3.9% | 90.06 16.6% | 77.25 20.9% | 63.92 30.8% | 48.87 2.7% | 47.57 5.5% | 50.35 18.6% | 42.46 |
| Div Payout | 57.0% 5.0% | 60.0% 0.0% | 60.0% 3.2% | 62.0% 13.9% | 72.0% 5.9% | 68.0% 1.5% | 67.0% 11.7% | 60.0% 9.1% | 66.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Liabilities | ||||||||||
| Equity Capital | ₹7 Cr 0.0% | ₹7 Cr 0.0% | ₹7 Cr 0.0% | ₹7 Cr 0.0% | ₹7 Cr 0.0% | ₹7 Cr 0.0% | ₹7 Cr 0.0% | ₹7 Cr 0.0% | ₹7 Cr 0.0% | ₹7 Cr |
| Reserves | ₹3.0K Cr 18.3% | ₹2.6K Cr 17.2% | ₹2.2K Cr 22.2% | ₹1.8K Cr 13.6% | ₹1.6K Cr 20.4% | ₹1.3K Cr 12.0% | ₹1.2K Cr 3.2% | ₹1.1K Cr 8.5% | ₹1.0K Cr 6.4% | ₹978 Cr |
| Borrowings | ₹297 Cr 18.8% | ₹250 Cr 431.9% | ₹47 Cr 43.4% | ₹83 Cr 37.1% | ₹132 Cr | ₹0 Cr 100.0% | ₹3 Cr 0.0% | ₹3 Cr | ₹0 Cr | ₹0 Cr |
| Other Liabilities | ₹1.3K Cr 11.1% | ₹1.1K Cr 6.2% | ₹1.1K Cr 11.0% | ₹956 Cr 20.6% | ₹793 Cr 11.4% | ₹895 Cr 74.1% | ₹514 Cr 3.8% | ₹495 Cr 11.0% | ₹446 Cr 11.5% | ₹400 Cr |
| Total Liabilities | ₹4.6K Cr 16.2% | ₹3.9K Cr 19.6% | ₹3.3K Cr 16.5% | ₹2.8K Cr 13.1% | ₹2.5K Cr 13.5% | ₹2.2K Cr 30.7% | ₹1.7K Cr 3.4% | ₹1.6K Cr 9.3% | ₹1.5K Cr 7.9% | ₹1.4K Cr |
Assets | ||||||||||
| Fixed Assets | ₹1.4K Cr 47.5% | ₹976 Cr 53.7% | ₹635 Cr 2.6% | ₹619 Cr 6.4% | ₹661 Cr 13.4% | ₹763 Cr 118.6% | ₹349 Cr 0.3% | ₹350 Cr 19.5% | ₹293 Cr 5.2% | ₹309 Cr |
| CWIP | ₹30 Cr 45.5% | ₹55 Cr 77.4% | ₹31 Cr 121.4% | ₹14 Cr 180.0% | ₹5 Cr 64.3% | ₹14 Cr 16.7% | ₹12 Cr 71.4% | ₹7 Cr 46.2% | ₹13 Cr 225.0% | ₹4 Cr |
| Investments | ₹1.2K Cr 18.8% | ₹1.5K Cr 37.7% | ₹1.1K Cr 54.6% | ₹683 Cr 5.9% | ₹645 Cr 35.5% | ₹476 Cr 5.1% | ₹453 Cr 5.0% | ₹477 Cr 9.1% | ₹525 Cr 12.9% | ₹465 Cr |
| Other Assets | ₹1.9K Cr 32.6% | ₹1.5K Cr 7.6% | ₹1.6K Cr 4.0% | ₹1.5K Cr 27.0% | ₹1.2K Cr 24.9% | ₹955 Cr 9.1% | ₹875 Cr 9.4% | ₹800 Cr 20.7% | ₹663 Cr 9.2% | ₹607 Cr |
| Total Assets | ₹4.6K Cr 16.2% | ₹3.9K Cr 19.6% | ₹3.3K Cr 16.5% | ₹2.8K Cr 13.1% | ₹2.5K Cr 13.5% | ₹2.2K Cr 30.7% | ₹1.7K Cr 3.4% | ₹1.6K Cr 9.3% | ₹1.5K Cr 7.9% | ₹1.4K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹756 Cr 1.2% | ₹765 Cr 1.9% | ₹780 Cr 71.1% | ₹456 Cr 13.2% | ₹403 Cr 19.4% | ₹500 Cr 12.1% | ₹446 Cr 17.7% | ₹379 Cr 30.2% | ₹291 Cr 4.3% | ₹279 Cr |
| Investing CF | ₹-267 Cr 31.0% | ₹-387 Cr 18.7% | ₹-326 Cr 452.5% | ₹-59 Cr 39.2% | ₹-97 Cr 67.7% | ₹-300 Cr 289.6% | ₹-77 Cr 20.3% | ₹-64 Cr 64.2% | ₹-179 Cr 842.1% | ₹-19 Cr |
| Financing CF | ₹-470 Cr 6.3% | ₹-442 Cr 8.3% | ₹-408 Cr 10.9% | ₹-368 Cr 26.5% | ₹-291 Cr 9.8% | ₹-265 Cr 15.7% | ₹-229 Cr 12.8% | ₹-203 Cr 8.6% | ₹-187 Cr 17.6% | ₹-227 Cr |
| Net Cash Flow | ₹18 Cr 128.1% | ₹-64 Cr 236.2% | ₹47 Cr 62.1% | ₹29 Cr 93.3% | ₹15 Cr 123.4% | ₹-64 Cr 145.7% | ₹140 Cr 26.1% | ₹111 Cr 248.0% | ₹-75 Cr 327.3% | ₹33 Cr |
| Free Cash Flow | ₹688 Cr 15.8% | ₹594 Cr 17.6% | ₹721 Cr 72.9% | ₹417 Cr 3.0% | ₹430 Cr 7.7% | ₹466 Cr 11.5% | ₹418 Cr 20.5% | ₹347 Cr 34.5% | ₹258 Cr 0.8% | ₹256 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 69d 11.3% | 62d 20.5% | 78d 22.0% | 100d 16.3% | 86d 50.9% | 57d 35.7% | 42d 28.8% | 59d 3.5% | 57d 16.3% | 49d |
| Inventory Days | — | — | — | — | — | — | — | — | — | — |
| Days Payable | — | — | — | — | — | — | — | — | — | — |
| Cash Conv. Cycle | 69d 11.3% | 62d 20.5% | 78d 22.0% | 100d 16.3% | 86d 50.9% | 57d 35.7% | 42d 28.8% | 59d 3.5% | 57d 16.3% | 49d |
| Working Capital Days | 5d 116.1% | -31d 342.9% | -7d | 0d 100.0% | -18d 48.6% | -35d 29.6% | -27d 200.0% | -9d 550.0% | 2d 128.6% | -7d |
| ROCE | 33.0% 2.9% | 34.0% 17.1% | 41.0% 0.0% | 41.0% 7.9% | 38.0% 2.7% | 37.0% 11.9% | 42.0% 6.7% | 45.0% 9.8% | 41.0% 8.9% | 45.0% |
Source: Screener.in · Lower days = better efficiency
About CRISIL Limited
CRISIL Ltd is a globally diversified analytical Company providing ratings, research, risk and policy advisory services. CRISIL is India’s leading ratings agency and the foremost provider of high-end research to large banks and leading corporations.[1]
Financial ServicesFinance